|
Company
Name |
Short
Summary |
Abpro |
Abpro is focused on a proprietary technology platform that allows for faster, more efficient production of recombinant proteins and antibodies. |
Acusphere |
Acusphere
is developing contrast agents for ultrasound,
computerized tomography, and magnetic resonance
imaging using synthetic polymer microencapusulation
technologies. |
Advanced
Magnetics |
Advanced
Magnetics, Inc. designs, develops and manufactures
contrast agents for Magnetic Resonance Imaging
(MRI). |
Agenus |
Agenus is focused on the research, development, and commercialization of vaccines and vaccine adjuvants. Agenus was formerly known as Antigenics. |
Agilent Technologies |
Agilent
Technologies is a global, diversified technology
company focusing on high-growth markets in the communications,
electronics, life sciences and healthcare industries. |
Avaxia Biologics |
Avaxia Biologics is focused on the research and development of antibody products for diseases of the GI tract. |
Concert Pharmaceuticals |
Concert Pharmaceuticals is focused on the research and development of novel drugs using deuterium instead of hydrogen which results in altered physiochemical and biological properties of the drug. |
Cubist
Pharmaceuticals |
Cubist
Pharmaceuticals, Inc. is a drug company focused
on the discovery, development and commercialization
of novel drugs to treat infections. |
Curis |
Curis is a focused on its signaling pathway drug technologies to identify targeted small molecule drug candidates for cancer. |
Predictive Biosciences |
Predictive Biosciences is focused on the development and commercialization of diagnostics to direct cancer therapy. |
Promedior |
Promedior is focused on the discovery and development of drugs to treat fibrotic, inflammatory and autoimmune diseases. |
Quanterix |
Quanterix is focused on utilizing its proprietary Single Molecule Array (SiMoA™) technology for the development and commercialization of diagnostic tests utilizing human blood. |
Synageva |
Synageva is focused on the research and development of treatments for patients with rare diseases. |
Synta Pharmaceuticals |
Synta Pharmaceuticals is focused on the discovery, research, and development of small molecule drugs with a focus on cancer and chronic inflammatory diseases. |
Taris Biomedical |
Taris Biomedical is a focused on the research and development of therapeutics which take advantage of local sustained delivery of therapeutics to the genitourinary system. |